V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007637 | 250012396 | 1.67 | 87.8 | Palliative (P) | null | 2013-10-20 | Trial Unspecified | N | N | 250032557 | DOCETAXEL |
| 250007638 | 250012396 | 1.67 | 0 | Disease modification (D) | 2015-01-07 | 2015-01-22 | Imatinib 400mg | Y | N | 250032557 | PEMETREXED |
| 250007639 | 250005325 | 1.73 | 67.3 | Curative (C) | 2015-10-17 | 2015-10-17 | FEC 60 or 75 | 02 | N | 250032560 | BENDAMUSTINE + RITUXIMAB |
| 250007640 | 250005326 | null | null | Disease modification (D) | 2015-10-13 | 2015-11-25 | Trial Unspecified | N | null | 250032561 | RUXOLITINIB |
| 250007642 | 250005328 | 1.78 | 68 | Palliative (P) | 2017-05-01 | 2017-05-11 | IPM | N | null | 250032564 | CARBO + GEFITINIB + PEMETREXED |
| 250007643 | 250005328 | 0 | 67.2 | Curative (C) | 2015-05-29 | 2015-06-02 | Trial Unspecified | 2 | N | 250032564 | CYTARABINE |
| 250007644 | 250005328 | 1.64 | 50.3 | Curative (C) | null | 2015-07-22 | Vinorelbine (oral) | null | N | 250032564 | MELPHALAN |
| 250007645 | 250005329 | 0 | 77.1 | null | 2012-02-27 | 2012-03-07 | MESO-02 TRIAL | 2 | N | 250032570 | BEVACIZUMAB |
| 250007646 | 250005330 | 0 | 0 | Palliative (P) | 2015-11-13 | 2015-11-13 | GemCarbo Days 1+8 | 2 | N | 250032571 | TRIAL |
| 250007647 | 250009792 | 1.44 | 95 | Disease modification (D) | 2013-12-23 | 2013-12-23 | Azacitidine | 02 | N | 250032572 | RUXOLITINIB |
| 250007648 | 250005331 | 0 | 73.8 | Disease modification (D) | 2017-08-13 | 2017-08-13 | MPT | N | Y | 250032575 | BENDAMUSTINE + RITUXIMAB |
| 250007649 | 250005331 | null | 67.7 | Curative (C) | 2015-02-27 | 2015-03-01 | Azacitidine | 02 | N | 250032575 | TRIAL |
| 250007650 | 250005332 | 1.63 | 0 | Disease modification (D) | null | 2014-11-11 | MESO-02 TRIAL | N | N | 250032581 | FEC |
| 250007651 | 250005332 | 1.7 | null | null | null | 2017-04-21 | GEMCITABINE | null | N | 250032581 | CYTARABINE |
| 250007652 | 250005333 | 1.73 | 66 | Palliative (P) | 2017-10-14 | 2017-10-15 | Azacitidine | N | N | 250032587 | MITOXANTRONE |
| 250007653 | 250005334 | 1.64 | 0 | Adjuvant (A) | 2017-08-19 | 2017-08-19 | Rituximab | N | N | 250032588 | VINORELBINE |
| 250007654 | 250005334 | 1.71 | 93 | Curative (C) | null | 2016-03-08 | Azacitidine | N | null | 250032588 | TRIAL |
| 250007655 | 250005335 | null | 79 | null | 2014-02-04 | 2014-02-22 | DA 3 + 10 | N | null | 250032601 | CYTARABINE |
| 250007656 | 250005335 | null | 80 | Palliative (P) | null | 2015-11-28 | Trial Unspecified | N | N | 250032601 | TRIAL |
| 250007657 | 250005335 | 1.67 | null | Curative (C) | 2014-09-27 | 2014-09-30 | ECarboX | 99 | N | 250032601 | CHOP R |
| 250007658 | 250005335 | 1.6 | 58.7 | Palliative (P) | 2016-07-22 | 2016-07-22 | Bortezomib +/- Dexamethasone | N | N | 250032601 | NOT MATCHED |
| 250007659 | 250005335 | 0 | 72.6 | Curative (C) | 2013-05-05 | 2013-05-05 | Pemetrexed | N | N | 250032601 | FLAG |
| 250007660 | 250005336 | 1.65 | 62.4 | null | 2013-03-12 | 2013-03-12 | Carboplatin AUC 2 - 5 | null | N | 250032609 | GEMCARBO |
| 250007661 | 250005337 | 1.5 | 0 | Curative (C) | 2013-08-02 | 2013-08-02 | CVP R | 2 | N | 250032613 | TRIAL |
| 250007662 | 250005337 | 1.53 | 73.2 | Disease modification (D) | 2014-08-27 | 2014-08-29 | Trial Unspecified | Y | N | 250032613 | PEMBROLIZUMAB |
| 250007664 | 250005339 | null | null | null | 2017-06-04 | 2017-06-04 | Trial Unspecified | 02 | N | 250032624 | TEMOZOLOMIDE |
| 250007665 | 250005340 | 1.62 | 0 | Palliative (P) | 2015-01-21 | 2015-01-21 | Trial Unspecified | N | N | 250032627 | TRIAL |
| 250007666 | 250005341 | 1.66 | 57 | Adjuvant (A) | 2017-05-03 | 2017-05-03 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | null | 250032628 | TRIAL |
| 250007667 | 250005341 | 0 | 77.5 | Disease modification (D) | 2018-04-06 | 2018-04-18 | Trial Unspecified | 02 | N | 250032628 | TRIAL |
| 250007668 | 250005342 | 1.76 | 100 | Not known (9) | 2017-07-20 | 2017-08-04 | BUSULFAN | 02 | N | 250032641 | COMMAND TRIAL |
| 250007669 | 250009799 | 1.78 | 103 | Palliative (P) | null | 2015-09-30 | R GCVP | 2 | N | 250032642 | TRIAL |
| 250007670 | 250009799 | null | 76.8 | null | 2013-07-19 | 2013-07-19 | CYTARABINE | 02 | N | 250032642 | SORAFENIB |
| 250007671 | 250009799 | null | null | null | 2017-04-02 | 2017-04-10 | Cisplatin | N | N | 250032642 | GEMCITABINE |
| 250007672 | 250005343 | null | null | Palliative (P) | 2016-03-15 | 2016-03-19 | Carboplatin AUC 2 - 5 | null | N | 250032650 | CARBOPLATIN |
| 250007673 | 250005343 | 1.65 | 64 | Palliative (P) | 2014-10-01 | 2014-10-09 | Trial Unspecified | N | N | 250032650 | GEMCARBO |
| 250007674 | 250005343 | 1.88 | 80 | Disease modification (D) | null | 2014-11-22 | Trial Unspecified | N | N | 250032650 | TRIAL |
| 250007675 | 250005344 | 1.79 | 60.8 | Palliative (P) | 2016-11-07 | 2016-11-16 | Trial Unspecified | 02 | N | 250032658 | RUXOLITINIB |
| 250007678 | 250005345 | 1.65 | 81.8 | Palliative (P) | 2016-03-25 | 2016-03-25 | Pemetrexed | N | null | 250032668 | CARBOPLATIN |
| 250007679 | 250005346 | 1.56 | null | null | 2013-06-18 | 2013-06-18 | IPM | 2 | N | 250032670 | PEMETREXED |
| 250007680 | 250009802 | 1.65 | 70 | Palliative (P) | 2016-04-07 | 2016-04-07 | Pemetrexed | N | N | 250032671 | PEMBROLIZUMAB |
| 250007681 | 250005347 | 1.8 | 73.6 | Disease modification (D) | 2013-12-10 | 2013-12-21 | Erlotinib | N | N | 250032672 | AZACITIDINE |
| 250007682 | 250005348 | 1.58 | null | Palliative (P) | 2017-04-26 | 2017-04-26 | Carboplatin + Paclitaxel (3 weekly) | 1 | N | 250032674 | AML17 TRIAL |
| 250007683 | 250005349 | null | 84 | Palliative (P) | null | 2016-08-21 | Cisplatin + Paclitaxel | N | N | 250032677 | CISPLATIN + GEMCITABINE |
| 250007684 | 250005349 | 1.63 | 59 | Disease modification (D) | 2015-08-13 | 2015-08-13 | Cytarabine Low Dose | 02 | N | 250032677 | VINORELBINE |
| 250007685 | 250005350 | null | 85 | Palliative (P) | 2017-08-15 | 2017-08-22 | Trial Unspecified | 02 | null | 250032680 | CARBOPLATIN + VINORELBINE |
| 250007686 | 250005351 | 1.83 | 75 | Palliative (P) | 2017-09-01 | 2017-09-01 | RUXOLITINIB | 2 | N | 250032684 | ENZALUTAMIDE |
| 250007687 | 250005352 | 0 | 0 | Palliative (P) | 2016-08-04 | 2016-08-04 | Trial Unspecified | N | N | 250032689 | TRIAL |
| 250007688 | 250005353 | 1.75 | 20.4 | Palliative (P) | 2017-10-30 | 2017-10-30 | RUXOLITINIB | 02 | N | 250032690 | RITUXIMAB |
| 250007689 | 250005353 | 1.64 | 0 | Palliative (P) | 2014-02-23 | 2014-02-25 | AML 18 TRIAL | 02 | N | 250032690 | AZACITIDINE |
| 250007690 | 250005354 | 1.7 | null | Disease modification (D) | null | 2016-01-23 | Azacitidine | Y | N | 250032695 | PEMETREXED |